Skip to main content
Genome&Company logo

Genome&Company — Investor Relations & Filings

Ticker · 314130 ISIN · KR7314130006 KO Manufacturing
Open in API
Filings indexed 427 across all filing types
Latest filing 2025-04-25 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 314130

About Genome&Company

http://genomecom.co.kr/

Genome&Company is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapeutics. The company's research and development pipeline is centered on two primary platforms: microbiome-based pharmaceuticals and novel immune checkpoint inhibitors for immuno-oncology. Its drug candidates are derived from its proprietary microbiome platform and are aimed at treating a range of diseases, with a significant focus on cancer. In addition to its pharmaceutical programs, the company develops and markets consumer healthcare products, including dietary supplements and cosmeceuticals, leveraging its expertise in microbes and probiotics.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자 결정) issued by Genome & Company. It details the issuance of new shares (third-party allocation), the purpose of the capital raise, share pricing, and conversion rights for preferred shares. This type of filing is a standard regulatory disclosure in the Korean market for capital structure changes and financing activities, which falls under the 'Share Issue/Capital Change' category.
2025-04-25 Korean
주요사항보고서(타법인주식및출자증권양수결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange regarding the acquisition of shares in another company (타법인 주식 및 출자증권 양수결정). It details the transaction, the valuation of the target company, and the counterparties involved. This type of regulatory filing in the Korean market is a standard disclosure for material corporate events, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually refers to full mergers/takeovers) or other specialized reports.
2025-04-25 Korean
주요사항보고서(자본으로인정되는채무증권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korea Exchange (KRX) regarding the decision to issue debt securities (convertible bonds) that qualify as capital. It details the terms of the issuance, including interest rates, conversion rights, and the purpose of the funds (acquisition of shares). This falls under the category of capital and financing updates, specifically for debt/equity issuance.
2025-04-24 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). This type of regulatory filing in the Korean market is used to disclose significant corporate financing activities, including the terms of the bond, conversion rights, and the list of investors. It falls under the category of capital and financing updates.
2025-04-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document is used to notify the market when an individual or entity crosses a significant ownership threshold (typically 5% or more) or changes their shareholding status. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2025-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, board member appointments, and amendments to the company's business purpose. Since it reports the official outcomes of the shareholder votes at the Annual General Meeting, it falls under the 'Declaration of Voting Results & Voting Rights Announcements' category.
2025-03-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.